Organogenesis Holdings (ORGO) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to -$46.8 million.
- Organogenesis Holdings' Retained Earnings rose 210.33% to -$46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.8 million, marking a year-over-year increase of 210.33%. This contributed to the annual value of -$40.1 million for FY2024, which is 210.15% up from last year.
- Organogenesis Holdings' Retained Earnings amounted to -$46.8 million in Q3 2025, which was up 210.33% from -$68.3 million recorded in Q2 2025.
- Over the past 5 years, Organogenesis Holdings' Retained Earnings peaked at -$40.1 million during Q4 2024, and registered a low of -$140.8 million during Q1 2021.
- Over the past 5 years, Organogenesis Holdings' median Retained Earnings value was -$52.8 million (recorded in 2022), while the average stood at -$62.4 million.
- In the last 5 years, Organogenesis Holdings' Retained Earnings surged by 6076.18% in 2021 and then crashed by 3797.42% in 2024.
- Organogenesis Holdings' Retained Earnings (Quarter) stood at -$60.8 million in 2021, then rose by 25.53% to -$45.3 million in 2022, then increased by 9.56% to -$41.0 million in 2023, then grew by 2.1% to -$40.1 million in 2024, then fell by 16.62% to -$46.8 million in 2025.
- Its Retained Earnings stands at -$46.8 million for Q3 2025, versus -$68.3 million for Q2 2025 and -$59.0 million for Q1 2025.